Mr. Andre Rancourt reports

TETRA BIO-PHARMA UPGRADES TO OTCQB TO ENGAGE AND EXPAND U.S. INVESTOR AUDIENCE

Effective tomorrow, shares of Tetra Bio Pharma Inc. have been approved for and will commence trading on the OTCQB Venture Marketplace, operated by OTC Markets Group, under the ticker symbol GRPOF. Shares of the company previously traded on the OTCQI Pink Sheet Market. The company also reiterated its strategy to create greater opportunity for its shareholders and attract new U.S. retail and institutional investors by providing transparency via this uplisting.

"We are extremely pleased to announce our uplist to the OTCQB Venture Marketplace," said Andre Rancourt, chief executive officer of Tetra Bio Pharma. "Tetra is committed to the high level of financial and corporate disclosure that is required for this listing category, which further demonstrates significant improvement in how we are categorized in the public markets. This move represents our expansion in growing our U.S. investor shareholder base as we believe that trading on the OTCQB will enhance trading liquidity and continue to increase market adoption of our business model, thereby enhancing shareholder value. We look forward to aggressively executing our business plan as we build a leading biopharmaceutical organization focused on developing medicinal cannabis as pharmaceutical drugs."

The OTCQB is considered by the Securities and Exchange Commission as an established public market for the purpose of determining the public market price when registering securities for resale with the SEC. The OTCQB dramatically increases transparency, reporting standards, management certification and compliance requirements; the majority of broker dealers trade stocks on the OTCQB. Historically, this has resulted in greater liquidity and awareness for companies that reach the OTCQB tier.

McMillan LLP serves as Tetra Bio Pharma's OTCQB adviser responsible for providing professional guidance on OTCQB requirements and U.S. securities laws.

We seek Safe Harbor.